Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D96DPA
|
|||
| Drug Name |
ECT-001
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 2 | [1] | |
| Company |
ExCellThera
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04103879) US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.